Delivery Order SPE2DB20D2014-SPE2DB25FB36T
Award Date 3/18/25
Potential Completion Date 3/19/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,516.70 firm fixed-price contract is for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin delivery device. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. This contract is not designated as a set-aside and appears to be part of...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,845.31, is for the procurement of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance that runs through May 15, 2024. This delivery order is part of a larger...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,249.77 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication, with a period of performance through July 10, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,925.76, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a brand-name insulin medication. The contract is a firm-fixed-price, delivery order type with an ultimate completion date of April 19, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication, with a ceiling value of $2,811.60 and a period of performance through February 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,391.36 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,199.67, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance through March 13, 2025. This award is not associated with a set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,470.32 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of February 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,419.86, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a period of performance through July 27, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,883.30, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of July 23, 2024....